A Study Evaluating Venetoclax Alone and in Combination With Azacitidine in Participants With Relapsed/Refractory Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to AbbVie
Related studies linked through entity extraction aliases.
A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of ABBV-428, an Immunotherapy, in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study With Upadacitinib (ABT-494) in Subjects From China and Selected Countries With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer Treatment
- Status
- WITHDRAWN
- Phase
- PHASE1
Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation
- Status
- COMPLETED
- Phase
- PHASE3
Viekira Pak or Mavyret Treatment for Patient With Chronic Kidney Disease and Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE4
Drug Use-Results Survey in Participants Infected With Hepatitis C Virus Genotype 2
- Status
- COMPLETED
- Phase
- N/A
Study of Veliparib in Combination With Nivolumab and Platinum Doublet Chemotherapy in Participants With Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study
- Status
- COMPLETED
- Phase
- PHASE3
An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate ABT-494 (Upadacitinib) in Adults With Moderate to Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis
- Status
- COMPLETED
- Phase
- N/A
Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics
- Status
- COMPLETED
- Phase
- N/A
HUMIRA® Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
- Status
- COMPLETED
- Phase
- N/A
Special Drug Use-results Survey of Duodopa Enteral Solution in Patients With Parkinson's Disease
- Status
- COMPLETED
- Phase
- N/A
Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa
- Status
- COMPLETED
- Phase
- PHASE3
Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2